logo

For the Inventor, By the Inventor

Burgdorf, Germany

Uwe Schoen

This inventor holds 22 USPTO granted patents and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Kali-Chemie Pharma Gmbh, Solvay Pharmaceuticals, Gmbh, Abbott Products Gmbh. Active years: 1985-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Uwe Schoen. Retrieved from https://idiyas.com/inventor/uwe-schoen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22

% Patents Active = 77.3

 

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 41(Granted Patents)


Location History:

  • Hanover, DE (1985 - 1988)
  • Burgdorf, DE (1988 - 2017)

Company Filing History:

goldMedal11 out of 92 
 
Kali-Chemie Pharma Gmbh
 patents
silverMedal7 out of 77 
 
Solvay Pharmaceuticals, Gmbh
 patents
bronzeMedal3 out of 17 
 
Abbott Products Gmbh
 patents
4. 3 out of 826 
 
Abbvie Inc.
 patents
where one patent can have more than one assignee

Years Active: 1985-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Hepatitis C Inhibitors
Cardiac Arrhythmia
Anti-Obesity Compounds
Triazoles
Piperazine
17BETA HSD Inhibitors
Neurokinin Antagonists
Pharmaceutical Compositions
Sulfamoyl Compounds
Bicyclo Compounds
Diuretic Treatment
Therapeutically Active
22 patents (USPTO):Explore Patents
1. 9567355 - Hepatitis C inhibitors and uses thereof (2017-02-14),
2. 9453007 - Hepatitis C inhibitors and uses thereof (2016-09-27),
3. 9173887 - Hepatitis C inhibitors and uses thereof (2015-11-03),
4. 8288367 - Substituted estratriene derivatives as 17BETA HSD inhibitors (2012-10-16),
5. 8080540 - Therapeutically active triazoles and their use (2011-12-20),
6. 7772225 - N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions (2010-08-10),
7. 7592344 - NK1 and NK2-antagonists and compositions and methods of using the same (2009-09-22),
8. 7547708 - N-sulfamoyl-N'-benzopyranpiperidine compounds and uses thereof (2009-06-16),
9. 6602880 - 3-phenyl-3,7-diazabicyclo[3.3.1] nonane compounds, process for preparing them, pharmaceutical compositions containing them and use thereof to inhibit cardiac arrhythmia (2003-08-05),
10. 6407106 - N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activity (2002-06-18),
11. 5843948 - Piperazinophenyl- and piperazinophenyloxycarboxylic acid derivatives, (1998-12-01),
12. 5635511 - Treatment of heart rhythm disorders by administration of (1997-06-03),
13. 5576327 - Treatment of heart rhythym disorders by administration of (1996-11-19),
14. 5532251 - Method of treating cardiac arrhythmia with 3-benzoyl-3, (1996-07-02),
15. 5324732 - Crystalline fumaric acid salts of 9,9-alkylene-3,7-diazabicyclononane (1994-06-28),

Title: The Innovative Journey of Uwe Schoen

Introduction:

Uwe Schoen, a visionary inventor hailing from Burgdorf, Germany, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents:

Uwe Schoen's latest patents include cutting-edge solutions in renewable energy technology, smart home devices, and advanced medical equipment, showcasing his versatility and forward-thinking approach.

Career Highlights:

Throughout his illustrious career, Uwe Schoen has been recognized for his pioneering work in artificial intelligence, robotics, and sustainable development. His inventions have revolutionized various industries, setting new standards for innovation.

Collaborations:

Uwe Schoen has collaborated with leading research institutions, universities, and multinational companies to bring his ideas to life. His partnerships have been instrumental in turning concepts into tangible products that have a positive impact on society.

Conclusion:

In conclusion, Uwe Schoen's passion for innovation, coupled with his relentless drive to push boundaries, has established him as a trailblazer in the world of technology. His inventive spirit continues to inspire the next generation of inventors and shape the future of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…